We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CUTR
2151
DELISTED
Cutera, Inc.
CUTR
| $2.98M | ﹤0.01% |
65,442
-92,635
| -59% | -$4.22M |
|
2152
Seres Therapeutics
MCRB
$48.4M
| $2.98M | ﹤0.01% |
23,236
+12,993
| +127% | +$1.33M |
|
2153
C3.ai
AI
$1.59B
| $2.98M | ﹤0.01% |
238,452
-5,081
| -2% | -$91.2K |
|
|
FBRT
2154
Franklin BSP Realty Trust
FBRT
$657M
| $2.98M | ﹤0.01% |
276,510
-101,441
| -27% | -$1.39M |
|
2155
Tidewater
TDW
$4.12B
| $2.98M | ﹤0.01% |
137,161
+2,836
| +2% | +$60.5K |
|
|
DAWN
2156
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.97M | ﹤0.01% |
448,770
+376,218
| +519% | +$8M |
|
2157
American Well
AMWL
$230M
| $2.96M | ﹤0.01% |
41,232
-787
| -2% | -$68.9K |
|
2158
Nicolet Bankshares
NIC
$3.62B
| $2.95M | ﹤0.01% |
41,828
-480
| -1% | -$37K |
|
|
ARIS
2159
DELISTED
Aris Water Solutions
ARIS
| $2.94M | ﹤0.01% |
230,579
-166,307
| -42% | -$2.84M |
|
|
VTLE
2160
DELISTED
Vital Energy
VTLE
| $2.94M | ﹤0.01% |
46,829
-14,268
| -23% | -$1.02M |
|
2161
Douglas Dynamics
PLOW
$1.02B
| $2.94M | ﹤0.01% |
104,910
+6,211
| +6% | +$189K |
|
2162
Dillards
DDS
$9.56B
| $2.94M | ﹤0.01% |
10,762
-10,201
| -49% | -$2.7M |
|
|
TBRG
2163
DELISTED
TruBridge
TBRG
| $2.93M | ﹤0.01% |
104,956
-16,768
| -14% | -$517K |
|
2164
Winmark
WINA
$1.32B
| $2.91M | ﹤0.01% |
13,470
-212
| -2% | -$46K |
|
2165
Shenandoah Telecom
SHEN
$746M
| $2.91M | ﹤0.01% |
170,970
-6,382
| -4% | -$136K |
|
2166
Uranium Energy
UEC
$5.57B
| $2.91M | ﹤0.01% |
831,125
+56,880
| +7% | +$217K |
|
2167
US Physical Therapy
USPH
$1.22B
| $2.9M | ﹤0.01% |
38,169
-20
| -0.1% | -$1.92K |
|
2168
GoPro
GPRO
$126M
| $2.9M | ﹤0.01% |
587,236
-378,027
| -39% | -$2.25M |
|
2169
Castle Biosciences
CSTL
$979M
| $2.89M | ﹤0.01% |
110,675
-1,980
| -2% | -$55.5K |
|
2170
Community Trust Bancorp
CTBI
$1.41B
| $2.88M | ﹤0.01% |
71,149
+13,017
| +22% | +$552K |
|
2171
BlueLinx
BXC
$706M
| $2.88M | ﹤0.01% |
46,338
-34,590
| -43% | -$2.49M |
|
|
FNA
2172
DELISTED
Paragon 28, Inc.
FNA
| $2.88M | ﹤0.01% |
161,446
+27,762
| +21% | +$511K |
|
|
NKLA
2173
DELISTED
Nikola Corporation Common Stock
NKLA
| $2.87M | ﹤0.01% |
27,178
+75
| +0.3% | +$12.7K |
|
2174
Protagonist Therapeutics
PTGX
$9.44B
| $2.85M | ﹤0.01% |
338,544
+572
| +0.2% | +$5.41K |
|
2175
Skywest
SKYW
$4.34B
| $2.85M | ﹤0.01% |
175,418
-45,214
| -20% | -$958K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.